JPS5484035A - Anti-allergic agent - Google Patents

Anti-allergic agent

Info

Publication number
JPS5484035A
JPS5484035A JP15228377A JP15228377A JPS5484035A JP S5484035 A JPS5484035 A JP S5484035A JP 15228377 A JP15228377 A JP 15228377A JP 15228377 A JP15228377 A JP 15228377A JP S5484035 A JPS5484035 A JP S5484035A
Authority
JP
Japan
Prior art keywords
pref
allergic agent
injection
trimethoxybenzyl
dose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP15228377A
Other languages
Japanese (ja)
Inventor
Hiroshi Kurokuzuhara
Yasutoshi Ono
Tokuhide Unno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Seiyaku Co Ltd
Original Assignee
Tanabe Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co Ltd filed Critical Tanabe Seiyaku Co Ltd
Priority to JP15228377A priority Critical patent/JPS5484035A/en
Priority to GB7848368A priority patent/GB2011887A/en
Priority to DE19782854343 priority patent/DE2854343A1/en
Publication of JPS5484035A publication Critical patent/JPS5484035A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Chemistry (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)

Abstract

PURPOSE: To provide a rapid-and long-acting anti-allergic agent effective to both prevention and control of the fit of asthema, administrable orally as well as by injection, containing trimethoxybenzyl tetrahydroisoquinoline derivative as an effective component.
CONSTITUTION: An anti-allergic agent in the form of tablet for oral administration, injection, inhalant, suppository, etc., containing, as an effective component, an isoquinoline derivative of formula I (Ring A is dihydroxybenzene ring of formula II or III, e.g. l-1-(3,4,5-trimethoxybenzyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (trimetoquinol). Dose for adult: 0.1-20 mg, pref. 0.1-10 mg/dose for oral administration, and 1μg-10 mg, pref. 1μg-1 mg, more pref. 1μg-0.1 mg for intravenous injection.
COPYRIGHT: (C)1979,JPO&Japio
JP15228377A 1977-12-16 1977-12-16 Anti-allergic agent Pending JPS5484035A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP15228377A JPS5484035A (en) 1977-12-16 1977-12-16 Anti-allergic agent
GB7848368A GB2011887A (en) 1977-12-16 1978-12-13 Antiallergic agent
DE19782854343 DE2854343A1 (en) 1977-12-16 1978-12-15 ANTIALLERGIC AGENT

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP15228377A JPS5484035A (en) 1977-12-16 1977-12-16 Anti-allergic agent

Publications (1)

Publication Number Publication Date
JPS5484035A true JPS5484035A (en) 1979-07-04

Family

ID=15537123

Family Applications (1)

Application Number Title Priority Date Filing Date
JP15228377A Pending JPS5484035A (en) 1977-12-16 1977-12-16 Anti-allergic agent

Country Status (3)

Country Link
JP (1) JPS5484035A (en)
DE (1) DE2854343A1 (en)
GB (1) GB2011887A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4385047A (en) * 1981-01-05 1983-05-24 Smithkline Beckman Corporation Antiallergic imidodisulfamides

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5170770A (en) * 1974-11-20 1976-06-18 Tanabe Seiyaku Co

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5170770A (en) * 1974-11-20 1976-06-18 Tanabe Seiyaku Co

Also Published As

Publication number Publication date
GB2011887A (en) 1979-07-18
DE2854343A1 (en) 1979-06-28

Similar Documents

Publication Publication Date Title
JPS5416478A (en) 3,4-dihydrocarbostyril herivative
JPS57116015A (en) Antitumor agent
JPS5484035A (en) Anti-allergic agent
GB1481930A (en) Dibenzo(a,g)quinolizinium compounds
JPS5217477A (en) Process for preparation of 1,2,3,4- tetrahydroisoquinolines and their salts
JPS5632423A (en) Promotion of thrombolytic activity of urokinase with crude drug extract, and pharmaceutical preparation containing the same
JPS5444035A (en) Antialergic agent
JPS53148539A (en) Antiallergic agnet
JPS5646808A (en) Carcinostatic agent
JPS5498339A (en) Carcinostatic agent
GB1004077A (en) Pharmaceutical compositions containing dibenzoquinolizines
JPS5742620A (en) Novel antiulcer agent
JPS57139066A (en) Isoquinoline derivative and its preparation
JPS5248692A (en) Preparation of homo-pyriimidazole derivatives
JPS5663972A (en) Preparation of novel benzothiazolone derivative containing novel heterocyclic quaternary salt
JPS5219647A (en) Preparation of 3-aminomethyl-4- homoisotwistane and its acid addition salt
JPS5422379A (en) Preparation of piperazine derivative
JPS55129265A (en) Interferon-inducing agent
JPS5622769A (en) Tetrahydroisoquinoline derivative and its preparation
JPS54105237A (en) Analgesic agent containing nalorphine-6-glucuronide
JPS545952A (en) Alkyphenethyldichlorosilanes and process for their preparation
JPS57126418A (en) Antiallergic agent
JPS51124193A (en) A method for preparing a polyester
JPS5210253A (en) Preparation of tetracyclo(5,4,1,13,10,07 13) tridecan-8-one
JPS5629600A (en) Novel 2-fluoro-n6,o2'-diacyl-adenosine-3',5'-cyclic phosphate, its preparation, and carcinostatic agent containing the same